XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:XuanZhu Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10948
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd, is a developer and manufacturer of medicinal products. The company’s products comprise anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydrochloride and anti-hypertensive drug tylerdipine hydrochloride. Its technology platforms include drug analysis lab, preparation research lab, lab for crystal form study and salt selection, BSL-2 lab, lab for pharmacokinetics and drug metabolism among others. The company offers products in therapeutic areas of cardiology, oncology, and others. XuanZhu is headquartered in Jinan, China.

XuanZhu Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Acquisition 12
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd – Key Competitors 13
XuanZhu Pharma Co Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
XuanZhu Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd, Key Competitors 13

List of Figures
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MILCOM Technologies, Inc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MILCOM Technologies, Inc Merger …
  • Fusion Partners Co. (4845):企業概要、財務及び戦略的SWOT分析
    Summary Fusion Partners Co. (Fusion Partners) is a technology solution provider. The company develops and provides database software. Its solutions include mainframe database solutions, intellectual property management solutions and business intelligence solutions. Fusion Partners offers technical s …
  • Marubeni Power International Inc:電力:M&Aディール及び事業提携情報
    Summary Marubeni Power International Inc (Marubeni Power International), formerly National Power Development Inc, a subsidiary of Marubeni Corp, is an energy service provider that offers electricity generation and transmission services. The company acquires established power generation portfolios an …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務情報
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Siemens AG (SIE):企業財務及び戦略的SWOT分析
    Siemens AG (SIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Titan Company Limited (TITAN):企業の財務及び戦略的SWOT分析
    Summary Titan Company Limited (Titan) is a watch manufacturing company that manufactures watches with quartz technology. The company operates in four business divisions namely; watches and accessories; jewellery; eyewear and precision engineering. Its jewellery division products include earring, pen …
  • Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular onco …
  • Astra Industrial Group (1212):企業財務及び戦略的SWOT分析
    Summary Astra Industrial Group (AIG) is an industrial conglomerate company that offers investment services. The company offers investment and economic development services. It delivers long-term stakeholder value through profitable and sustainable growth. AIG offers economic development through the …
  • Diaxonhit S.A. (ALEHT):企業のM&A・提携動向(医療機器分野)
    Summary Diaxonhit S.A. (Diaxonhit) is a biotechnology company that offers diagnostic products. The company’s activities include discovery to the marketing of specialty diagnostic products. Its products include TQS used in treatment of teanus; BJI InoPlex used to treatment of prosthetic infection and …
  • AusNet Services Ltd (AST):電力:M&Aディール及び事業提携情報
    Summary AusNet Services Ltd. (AusNet) is a diversified energy network business entity that transmits and distributes power and distributes gas. It owns and manages electricity transmission network in Victoria; and delivers electricity to various customer connection points in eastern Victoria includi …
  • WestRock Co:戦略・SWOT・企業財務分析
    WestRock Co - Strategy, SWOT and Corporate Finance Report Summary WestRock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Win Hanverky Holdings Limited (3322):企業財務及び戦略的SWOT分析
    Summary Win Hanverky Holdings Limited (Win Hanverky) is a consumer goods company that manufactures, distributes, and retails sportswear products. The company operates through manufactures sportswear and golf and high-end fashion apparel under original equipment manufacturing arrangements for interna …
  • SAF-HOLLAND S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SAF-HOLLAND S.A. Mergers and Ac …
  • Ramco Cements Ltd:企業の戦略・SWOT・財務情報
    Ramco Cements Ltd - Strategy, SWOT and Corporate Finance Report Summary Ramco Cements Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gadeta BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Gadeta BV (Gadeta) is a biotechnology company, which focuses on the research and development of cellular immunotherapies for the elimination of cancer. The company’s technology platform combines alpha beta T cells engineered to express defined Gamma Delta T cell receptors (TEGs) that demonst …
  • Alpiq Holding AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alpiq Holding AG Mergers and Ac …
  • SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology …
  • Metromedia International Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Metromedia International Group, …
  • SynCo Bio Partners B.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SynCo Bio Partners B.V. Mergers …
  • NuGEN Technologies, Inc.(製薬・医療分野):企業M&A動向
    Summary NuGEN Technologies, Inc. (NuGEN) is a medical device company. The company provides genomics sample preparation solutions which helps scientists to access true biology in samples, independent of type, amount and quality for analysis on analytical platforms. Its products include Applause, Enco …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆